Kate Sawkins
Barker Street, Randwick
Sydney, NSW 2031, Australia
Sydney, NSW 2031, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Continuing or ceasing bevacizumab beyond progression in recurrent glioblastoma: an exploratory randomized phase II trial.
Journal: Neuro-oncology practice
Published: September 01, 2017
The role of early magnetic resonance imaging in predicting survival on bevacizumab for recurrent glioblastoma: Results from a prospective clinical trial (CABARET).
Journal: Cancer
Published: February 14, 2017
Comparison between site and central radiological assessments for patients with recurrent glioblastoma on a clinical trial.
Journal: Asia-Pacific journal of clinical oncology
Published: January 31, 2017
Health-related quality of life outcomes from CABARET: a randomized phase 2 trial of carboplatin and bevacizumab in recurrent glioblastoma.
Journal: Journal of neuro-oncology
Published: November 14, 2016
Validating self-report and proxy reports of the Dexamethasone Symptom Questionnaire -Chronic for the evaluation of longer-term corticosteroid toxicity.
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: April 17, 2015
Evolving management of low grade glioma: No consensus amongst treating clinicians.
Journal: Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia
Published: March 31, 2015
Randomized phase 2 study of carboplatin and bevacizumab in recurrent glioblastoma.
Journal: Neuro-oncology
Published: March 13, 2015
Culturally and linguistically diverse patient participation in glioma research.
Journal: Neuro-oncology practice
Published: February 18, 2014
Showing 1-8 of 8
Last Updated: 09/26/2026